Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Staber Philipp |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Kazianka, L; Pichler, A; Agreiter, C; Rohrbeck, J; Kornauth, C; Porpaczy, E; Sillaber, C; Sperr, WR; Gleixner, KV; Hauswirth, A; Jäger, U; Valent, P; Jonak, C; Porkert, S; Exner, R; Willenbacher, W; Wolf, D; Neumeister, P; Prochazka, K; Deutsch, A; Greil, R; Schmitt, C; Ristl, R; Mayerhoefer, M; Simonitsch-Klupp, I; Pemovska, T; Staber, PB Comparing functional and genomic-based precision medicine in blood cancer patients.
Hemasphere. 2025; 9(4):e70129 Doi: 10.1002/hem3.70129 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2023

Abstract (Journal)

** Kazianka, L; Pemovska, T; Rohrbeck, J; Kornauth, C; Pichler, A; Agreiter, C; Hauptmann, L; Lubowitzki, S; Prochazka, K; Neumeister, P; Schmitt, C; Greil, R; Willenbacher, W; Wolf, D; Simonitsch-Klupp, ; Staber, P Precision medicine in clinical routine: feasibility results from the multicentric prospective randomized controlled EXALT-2 Study
ONCOL RES TREAT. 2023; 46: 293-294. [Poster]
Web of Science

 

** Kazianka, L; Pemovska, T; Rohrbeck, J; Kornauth, C; Pichler, A; Agreiter, C; Lubowitzki, S; Prochazka, K; Neumeister, P; Schmitt, C; Greil, R; Willenbacher, W; Wolf, D; Jaeger, U; Simonitsch-Klupp, I; Staber, PB Functional Precision Medicine Vs Genomics Vs Clinical Experience: Feasibility Results from the Multicentric, Prospective, Randomized Controlled Exalt-2 Trial
BLOOD. 2023; 142: Doi: 10.1182/blood-2023-189856
Web of Science FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Staber, PB; Jurczak, W; Greil, R; Vucinic, V; Middeke, JM; Montillo, M; Munir, T; Neumeister, P; Schetelig, J; Stilgenbauer, S; Striebel, F; Dirnberger-Hertweck, M; Weirather, J; Brugger, W; Kelemen, P; Wendtner, CM; Woyach, JA Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.
Leuk Lymphoma. 2021; 62(14):3440-3451 Doi: 10.1080/10428194.2021.1964020
Web of Science PubMed FullText FullText_MUG

 

** van, der, Kouwe, E; Heller, G; Czibere, A; Pulikkan, JA; Agreiter, C; Castilla, LH; Delwel, R; Di, Ruscio, A; Ebralidze, AK; Forte, M; Grebien, F; Heyes, E; Kazianka, L; Klinger, J; Kornauth, C; Le, T; Lind, K; Barbosa, IAM; Pemovska, T; Pichler, A; Schmolke, AS; Schweicker, CM; Sill, H; Sperr, WR; Spittler, A; Surapally, S; Trinh, BQ; Valent, P; Vanura, K; Welner, RS; Zuber, J; Tenen, DG; Staber, PB Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.
Blood. 2021; 138(15):1345-1358 Doi: 10.1182/blood.2020008971 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Full paper/article (Journal)

** Staber, PB; Zhang, P; Ye, M; Welner, RS; Nombela-Arrieta, C; Bach, C; Kerenyi, M; Bartholdy, BA; Zhang, H; Alberich-Jorda, M; Lee, S; Yang, H; Ng, F; Zhang, JY; Leddin, M; Silberstein, LE; Hoefler, G; Orkin, SH; Gottgens, B; Rosenbauer, F; Huang, G; Tenen, DG; Sustained PU.1 Levels Balance Cell-Cycle Regulators to Prevent Exhaustion of Adult Hematopoietic Stem Cells.
MOL CELL. 2013; 49(5): 934-946. Doi: 10.1016/j.molcel.2013.01.007 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ye, M; Zhang, H; Amabile, G; Yang, H; Staber, PB; Zhang, P; Levantini, E; Alberich-Jorda, M; Zhang, JY; Kawasaki, A; Tenen, DG; C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence.
Nat Cell Biol. 2013; 15(4):385-394 Doi: 10.1038/ncb2698 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Höfler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, M; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.
Nat Med. 2012; 18(11):1699-1704 Doi: 10.1038/nm.2966 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Abstract (Journal)

** Kenner, L; Laimer, D; Dolznig, H; Vesely, P; Kollmann, K; Schiefer, AII; Sexl, V; Staber, PB; Hoefler, G; Penninger, J; Inghirami, G; Ulrich, J New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas
BLOOD. 2011; 118(21): 721-721.
Web of Science

 

2010

Full paper/article (Journal)

** Will, B; Siddiqi, T; Alberich Jordà, M; Shimamura, T; Luptakova, K; Staber, PB; Costa, DB; Steidl, U; Tenen, DG; Kobayashi, S Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells.
Blood. 2010; 115(14):2901-2909 Doi: 10.1182/blood-2009-03-209544 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Langner, S; Staber, P; Linkesch, W; Strunk, D Long-term follow-up of minimal chronic graft-versus-host disease after reduced-intensity conditioning with pre-transplant low dose anti-thymocyte globulin in allogeneic stem cell transplantation
BONE MARROW TRANSPLANT. 2010; 45: S145-S145. - 36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

2009

Full paper/article (Journal)

** Finke, J; Bethge, WA; Schmoor, C; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Ruutu, T; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhäuser, M; Einsele, H; Kolb, HJ; Bertz, H; Egger, M; Grishina, O; Socié, G; ATG-Fresenius Trial Group Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol. 2009; 10(9): 855-864. Doi: 10.1016/S1470-2045(09)70225-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Vesely, PW; Staber, PB; Hoefler, G; Kenner, L Translational regulation mechanisms of AP-1 proteins.
Mutat Res. 2009; 682(1):7-12 Doi: 10.1016/j.mrrev.2009.01.001
Web of Science PubMed FullText FullText_MUG

 

2008

Full paper/article (Journal)

** Langner, S; Staber, PB; Neumeister, P Posaconazole in the management of refractory invasive fungal infections.
Ther Clin Risk Manag. 2008; 4(4): 747-758. Doi: 10.2147/TCRM.S3329 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Langner, S; Staber, PB; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Urban, C; Linkesch, W; Neumeister, P Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
Bone Marrow Transplant. 2008; 42(4): 275-279. Doi: 10.1038/bmt.2008.157 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zollner-Schwetz, I; Auner, HW; Paulitsch, A; Buzina, W; Staber, PB; Ofner-Kopeinig, P; Reisinger, EC; Olschewski, H; Krause, R Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation.
J Infect Dis. 2008; 198(1): 150-153. Doi: 10.1086/588827 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Full paper/article (Journal)

** Deutsch, AJ; Aigelsreiter, A; Staber, PB; Beham, A; Linkesch, W; Guelly, C; Brezinschek, RI; Fruhwirth, M; Emberger, W; Buettner, M; Beham-Schmid, C; Neumeister, P MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Blood. 2007; 109(8):3500-3504 Doi: 10.1182/blood-2006-06-030494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Staber, PB; Vesely, P; Haq, N; Ott, RG; Funato, K; Bambach, I; Fuchs, C; Schauer, S; Linkesch, W; Hrzenjak, A; Dirks, WG; Sexl, V; Bergler, H; Kadin, ME; Sternberg, DW; Kenner, L; Hoefler, G The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.
Blood. 2007; 110(9):3374-3383 Doi: 10.1182/blood-2007-02-071258 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Review

** Staber, P; Langner, S; Dornbusch, HJ; Neumeister, P Antifungal management in cancer patients.
Wien Med Wochenschr. 2007; 157(19-20):503-510 Doi: 10.1007/s10354-007-0466-y
PubMed FullText FullText_MUG

 

Abstract (Journal)

** Fuchs, C; Vesely, P; Bambach, I; Schauer, S; Linkesch, W; Stemberg, DW; Hoefler, G; Staber, PB Identification of critical phosporylation sites within NPM-ALK that regulate JUNB mRNA translation
BLOOD. 2007; 110(11):1044A-1045A.-49 th Annual Meeting of the American Society of Hematology; NOV 8-11, 2007; Atlanta, Georgia, USA. [Poster]
Web of Science

 

** Laimer, D; Vesely, P; Staber, P; Pflegerl, P; Brandes, R; Schlederer, M; Hoefler, G; Kenner, L Role of junb in ALCL lymphoma development
HAEMATOL-HEMATOL J. 2007; 92: 344-344.Vienna. [Poster]
Web of Science

 

** Langner, S; Staber, P; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Linkesch, W; Neumeister, P Palifermin in unrelated donor transplant recipients
HAEMATOL-HEMATOL J. 2007; 92: 172-173. [Poster]
Web of Science

 

** Langner, S; Staber, P; Strunk, D; Linkesch, W Decreased chronic GVHD rate after reduced intensity conditioning with low dose ATG in allogeneic hematopoietic SCT
HAEMATOL-HEMATOL J. 2007; 92: 220-220.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Staber, P; Vesely, P; Fuchs, C; Bambach, I; Schauer, S; Bergler, H; Sternberg, D; Hoefler, G The oncoprotein NPM-ALK induces translation of AP-1 factors via mTOR signalling
HAEMATOL-HEMATOL J. 2007; 92: 344-344.Vienna. [Oral Communication]
Web of Science

 

** Staber, PB; Vesely, P; Fuchs, C; Schauer, S; Sternberg, DW; Hoefler, G NPM-ALK induces JUNB and converts its role from a tumor suppressor to an oncogene
FEBS J. 2007; 274: 150-150. [Poster]
Web of Science

 

** Vesely, P; Staber, P; Fuchs, C; Bambach, I; Schauer, S; Sternberg, D; Kenner, L; Hoefler, G Expression of NPM-ALK leads to oncogenic effects of JunB
HAEMATOL-HEMATOL J. 2007; 92: 107-107.Vienna. [Oral Communication]
Web of Science

 

** Vesely, P; Staber, PB; Fuchs, C; Schauer, S; Bergler, H; Sternberg, DW; Hoefler, G Translational control of JUNB via the fusion tyrosine kinase NPM-ALK in ALC(L) lymphoma
FEBS J. 2007; 274: 150-150. [Poster]
Web of Science

 

2006

Full paper/article (Journal)

** Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Staber, PB; Zatloukal, K; Denk, H Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
Mol Cancer Ther. 2006; 5(9):2203-2210 Doi: 10.1158/1535-7163.MCT-05-0480 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Penack, O; Beinert, T; Buchheidt, D; Einsele, H; Hebart, H; Kiehl, MG; Massenkeil, G; Schiel, X; Schleicher, J; Staber, PB; Wilhelm, S; Wolf, HH; Wolf, H; Ostermann, H; German Society of Hematology and Oncology Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ann Hematol. 2006; 85(7):424-433 Doi: 10.1007/s00277-006-0096-2
Web of Science PubMed FullText FullText_MUG

 

** Staber, PB; Noehammer, C; Dürkop, H; Schauer, S; Kenner, L; Linkesch, W; Hoefler, G mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
Leuk Res. 2006; 30(3):343-348 Doi: 10.1016/j.leukres.2005.08.010
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zebisch, A; Staber, PB; Delavar, A; Bodner, C; Hiden, K; Fischereder, K; Janakiraman, M; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Cancer Res. 2006; 66(7):3401-3408 Doi: 10.1158/0008-5472.CAN-05-0115 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Fruehwirth, M; Deutsch, AJA; Staber, PB; Aigelsreiter, A; Linkesch, W; Beham-Schimid, C; Neumeister, P Aberrant somatic hypermutation of follicular lymphoma transformed to diffuse large B-cell lymphoma.
BLOOD. 2006; 108(11): 683A-683A. Doi: 10.1182/blood.V108.11.2413.2413 [Poster]
Web of Science FullText FullText_MUG

 

** Langner, S; Staber, P; Radspieler, G; Triebl-Roth, K; Urban, C; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Neumeister, P Palifermin reduces oral mucositis and enhances the recovery of intestinal mucosa measured by citrulline serum levels in allogeneic and autologous stem cell transplant recipients
BONE MARROW TRANSPLANT. 37: S73-S74.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Poster]
Web of Science

 

** Langner, S; Staber, PB; Zebisch, A; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Greinix, H; Kalhs, P; Rabitsch, W; Neumeister, P Adding palifermin in allogeneic and autologous stem cell transplantation resulted in reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels.
BLOOD. 2006; 108(11): 404B-404B. Doi: 10.1182/blood.V108.11.5251.5251 [Poster]
Web of Science FullText FullText_MUG

 

** Staber, PB; Vesely, P; Ott, R; Haq, N; Linkesch, W; Schauer, S; Hrzenjak, A; Kenner, L; Dirks, W; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma exerts its transforming potential by increasing translation of JUNB through mTOR and S6K1.
BLOOD. 2006; 108(11): 414A-415A. Doi: 10.1182/blood.V108.11.1428.1428 [Poster]
Web of Science FullText FullText_MUG

 

** Vesely, P; Staber, PB; Ott, R; Pinent, M; Linkesch, W; Schauer, S; Hrzenjak, A; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK converts JUNB from a tumor suppressor to an oncogene.
BLOOD. 2006; 108(11): 419A-420A. Doi: 10.1182/blood.V108.11.1448.1448 [Poster]
Web of Science FullText FullText_MUG

 

2005

Full paper/article (Journal)

** Macher, S; Schallmoser, K; Staber, PB; Neumeister, P; Posch, U; Lanzer, G; Panzer, S Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.
VOX SANG. 2005; 89(4): 257-260. Doi: 10.1111/j.1423-0410.2005.00692.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Staber, PB; Holub, R; Linkesch, W; Schmidt, H; Neumeister, P Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.
BONE MARROW TRANSPLANT. 2005; 35(9): 889-893. Doi: 10.1038/sj.bmt.1704927 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Macher, S; Schallmoser, K; Staber, P; Neumeister, P; Rosskopf, K; Posch, U; Panzer, S; Lanzer, G Severe immune thrombocytopenia due to HPA-1 a host-derived antibodies after non-myeloablative allogeneic hematopoetic stem cell transplantation for multiple myeloma
TRANSFUSION 2005 45: 114A-114A.
Web of Science

 

2004

Full paper/article (Journal)

** Staber, PB; Linkesch, W; Zauner, D; Beham-Schmid, C; Guelly, C; Schauer, S; Sill, H; Hoefler, G Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia.
Oncogene. 2004; 23(4):894-904 Doi: 10.1038/sj.onc.1207192 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Neumeister, P; Holub, R; Staber, PB; Linkesch, W Pegfilgrastim shows safety and efficacy similar to filgrastim in patients undergoing autologous stem cell transplantation for hematological malignancies.
BLOOD 2004 104: 327A-327A. Doi: 10.1182/blood.V104.11.1156.1156
Web of Science FullText FullText_MUG

 

** Staber, PB; Linkesch, W; Schauer, S; Moser, G; Kadin, ME; Dirks, W; Hoefler, G Genes regulated by NPM-ALK fusion kinase play a key role in the activation of AP-1 transcription factors.
BLOOD 2004 104: 74A-74A. Doi: 10.1182/blood.V104.11.245.245
Web of Science FullText FullText_MUG

 

** Zebisch, A; Staber, PB; Fischereder, K; Bodner, C; Hiden, K; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H Two novel activating germline mutations of the C-RAF proto-oncogene predisposing to solid tbmors and therapy-related acute myeloid leukemia.
BLOOD 2004 104: 920A-920A. Doi: 10.1182/blood.V104.11.3370.3370
Web of Science FullText FullText_MUG

 

** Zinke-Cerwenka, W; Eibl, M; Sill, H; Hofler, G; Staber, P; Linkesch, W Continuous molecular response after discontinuation of imatinib mesylate following relapse after non-myeloablative allogeneic stem cell transplantation for CML
BONE MARROW TRANSPLANT 2004 33: S348-S348.
Web of Science

 

2003

Full paper/article (Journal)

** Nöhammer, C; Brunner, F; Wölkart, G; Staber, PB; Steyrer, E; Gonzalez, FJ; Zechner, R; Hoefler, G Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle.
Lab Invest. 2003; 83(2):259-269 Doi: 10.1097/01.LAB.0000053916.61772.CA [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Staber, PB; Brezinschek, R; Linkesch, W; Sill, H; Neumeister, P Durable molecular response to imatinib mesylate following nonmyeloablative allogeneic stem-cell transplantation for persisting myeloid blast crisis in chronic myeloid leukemia.
Haematologica. 2003; 88(8):ECR29-ECR29 (- Case Report) [OPEN ACCESS]
PubMed Google Scholar

 

Abstract (Journal)

** Höfler, G; Staber, PB; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate and activation of the B-RAF/MEK/Erk pathway at relapse of acute myeloid leukemia
MODERN PATHOL 2003 16: 235A-236A.
Web of Science

 

** Höfler, G; Staber, PB; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate and activation of the B-RAF/MEK/erk pathway at relapse of acute myeloid leukemia
LAB INVEST 2003 83: 235A-236A.
Web of Science

 

** Staber, PB; Neumeister, P; Duerkop, H; Schauer, S; Linkesch, W; Hoefler, G CD30 induced cell death in anaplastic large cell lymphoma involves perforin/granzyme cell death pathway and the caspase dependent death receptors TNFR-1 and FAS/APO-1.
BLOOD 2003 102: 885A-885A.
Web of Science

 

2002

Abstract (Journal)

** Bernhart, E; Noehammer, C; Staber, P; Schaffer, P; Höfler, G; Koidl, B A mouse model of metabolic cardiomyopathy shows alterations of ventricular electrophysiology
BIOPHYS J 2002 82: 477-477.
Web of Science

 

** Staber, PB; Hoefler, G; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate in acute myeloid leukemia blasts at relapse due to activation of the B-Raf/MEK/Erk pathway.
BLOOD 2002 100: 330A-330A.
Web of Science

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint